Tompkins VS - Search Results

1

RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts.

Zhang X, Hagen J, Muniz VP, Smith T, Coombs GS, Eischen CM, Mackie DI, Roman DL, Van Rheeden R, Darbro B, Tompkins VS, Quelle DE. Zhang X, et al. Among authors: tompkins vs. PLoS One. 2013 Nov 25;8(11):e80228. doi: 10.1371/journal.pone.0080228. eCollection 2013. PLoS One. 2013. PMID: 24282525 Free PMC article.

2

Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.

Zhao L, Samuels T, Winckler S, Korgaonkar C, Tompkins V, Horne MC, Quelle DE. Zhao L, et al. Mol Cancer Res. 2003 Jan;1(3):195-206. Mol Cancer Res. 2003. PMID: 12556559

3

Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.

Korgaonkar C, Hagen J, Tompkins V, Frazier AA, Allamargot C, Quelle FW, Quelle DE. Korgaonkar C, et al. Mol Cell Biol. 2005 Feb;25(4):1258-71. doi: 10.1128/MCB.25.4.1258-1271.2005. Mol Cell Biol. 2005. PMID: 15684379 Free PMC article.

4

Identification of novel ARF binding proteins by two-hybrid screening.

Tompkins V, Hagen J, Zediak VP, Quelle DE. Tompkins V, et al. Cell Cycle. 2006 Mar;5(6):641-6. Epub 2006 Mar 15. Cell Cycle. 2006. PMID: 16582619

5

A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability.

Tompkins VS, Hagen J, Frazier AA, Lushnikova T, Fitzgerald MP, di Tommaso A, Ladeveze V, Domann FE, Eischen CM, Quelle DE. Tompkins VS, et al. J Biol Chem. 2007 Jan 12;282(2):1322-33. doi: 10.1074/jbc.M609612200. Epub 2006 Nov 16. J Biol Chem. 2007. PMID: 17110379 Free article.

6

Generation and characterization of monoclonal antibodies to NIAM: a nuclear interactor of ARF and Mdm2.

Hagen J, Tompkins V, Dudakovic A, Weydert JA, Quelle DE. Hagen J, et al. Hybridoma (Larchmt). 2008 Jun;27(3):159-66. doi: 10.1089/hyb.2007.0533. Hybridoma (Larchmt). 2008. PMID: 18582208 Free PMC article.

7

Residues in the alternative reading frame tumor suppressor that influence its stability and p53-independent activities.

di Tommaso A, Hagen J, Tompkins V, Muniz V, Dudakovic A, Kitzis A, Ladeveze V, Quelle DE. di Tommaso A, et al. Exp Cell Res. 2009 Apr 15;315(7):1326-35. doi: 10.1016/j.yexcr.2009.01.010. Epub 2009 Jan 27. Exp Cell Res. 2009. PMID: 19331830 Free PMC article.

8

RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients.

Muniz VP, Askeland RW, Zhang X, Reed SM, Tompkins VS, Hagen J, McDowell BD, Button A, Smith BJ, Weydert JA, Mezhir JJ, Quelle DE. Muniz VP, et al. Among authors: tompkins vs. Genes Cancer. 2013 Jul;4(7-8):273-84. doi: 10.1177/1947601913501074. Genes Cancer. 2013. PMID: 24167655 Free PMC article.

9

Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53.

Reed SM, Hagen J, Tompkins VS, Thies K, Quelle FW, Quelle DE. Reed SM, et al. Among authors: tompkins vs. Cell Cycle. 2014;13(8):1288-98. doi: 10.4161/cc.28202. Epub 2014 Feb 19. Cell Cycle. 2014. PMID: 24621507 Free PMC article.

10

NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas.

Reed SM, Hagen J, Muniz VP, Rosean TR, Borcherding N, Sciegienka S, Goeken JA, Naumann PW, Zhang W, Tompkins VS, Janz S, Meyerholz DK, Quelle DE. Reed SM, et al. Among authors: tompkins vs. PLoS One. 2014 Nov 13;9(11):e112126. doi: 10.1371/journal.pone.0112126. eCollection 2014. PLoS One. 2014. PMID: 25393878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters